TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Frequency of ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of AMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of arterial thrombotic complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: BSH discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Urinary urgency score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of patients with intraoperative observed fluorescence of pituitary tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Nerve fiber density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity to thermal and tactile stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AHI Event Detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence Patients Experiencing Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Intraoperative mechanical power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total microbiotic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed COVID-19 and presence of at least 1 symptom
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with anti-hemagglutinin inhibition (HI) titers >= 1:40
Endpoint domain: Physiological/clinical
Primary endpoint: Visual Comparison Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction Evaluation Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MammoWave® sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MammoWave® specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lung function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Chest expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Manchester Related Activities of Daily Living Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pre-diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Numeric Pain Rate Scale (NPRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participants complete pathologic response (CPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with pregnancy success
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with pregnancy loss
Endpoint domain: Mortality/survival
Primary endpoint: Change in EarliPoint Index Scores in typically developing children
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in EarliPoint Index Scores in ASD/DD children
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in LVEDVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of ICU delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anatomic hiatal hernia recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Positive serology for SARS CoV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Treatment failure or mortality
Endpoint domain: Mortality/survival
Primary endpoint: Cmax for Dabigatran (Total and Free)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 for Dabigatran (Total and Free)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t for Dabigatran (Total and Free)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression features
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anxiety features
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Driving Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shortened time to vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: high-sensitive C-Reactive Protein (hs-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of voidings and intensity of urgencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent changes in biomarker levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee joint range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montreal Cognitive Rating Scale (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal fluency test (VF)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility of low-protein diet intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Immunogenicity and durability of rVSVDG-ZEBOV-GP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Remission of depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cVEMP signal quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intratumor heterogeneity (ITH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean change score in Quality of Life Assessment Tool (EORTC-QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in MRD1 in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in proptosis in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in stigma levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual functional questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Visual functioning
Primary endpoint: Changes in relative species abundance of intestinal bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in body fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Pain Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neck Pain Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in constipation status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Substance use related consequences
Endpoint domain: Adverse events/effects
Primary endpoint: Course of hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity of transverse diameter of right common femoral vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity and specificity of pathogen detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: C-reactive protein concentrations in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Creatine kinase concentrations in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cortisol concentrations in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Interleukin-8 concentrations in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumor necrosis factor-alpha concentrations in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Copper-zinc superoxide dismutase concentrations in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve from Time 0 to the Last Time Point Evaluated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent total plasma clearance of drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Irritation Score (MIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number and proportion of subjects sensitized
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sleep quality Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Rigidity of the upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Tremor of the upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Escala DASH
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Escala KOOS-PS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of treatment related AEs, AEs of special interest and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Neck specific disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Blood-Brain-Barrier Permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with optimally located cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor residual rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent weight lost
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Postoperative Wound Complications
Endpoint domain: Adverse events/effects
Primary endpoint: change in visual analog scale (VAS) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: single assessment numerical evaluation (SANE) of the shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxford shoulder score (OSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American shoulder and elbow surgeons (ASES) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural-excursion efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high-sensitivity troponin T levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of ultrasound signs of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Grade of ophthalmology examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICP-MS results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ISQ result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Gut microbiota composition and diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants meeting ACR 20 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait speed and distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: referred pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic self-confidence score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comprehensive diagnostic efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Borg scale of exertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of steps during visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of parasites associated with IBD and IBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Montreal Cognitive Assessment Scale (MOCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Standard Mini mental test (SMMT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Beck depression scale (BDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: A single Likert type question in the Pittsburgh questionnaire (Sleep quality)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: SAMS-CI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPI
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: blood dopamine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-term nutritional recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Implantation Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Postural equilibrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Positive COVID-19 Test Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SARS Cov-2 RT-PCR test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient-Rated Wrist evaluation (PRWE)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overnight sleep physiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy beliefs for providing ethnic/racial support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coping efficacy with discrimination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Community connectedness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cerebrovascular Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inspiratory Muscle Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Uptake of smoking cessation resources
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of 'yes' responses to intended use question
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: amount of free gingival graft contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of OCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee pain during the last week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee-related physical function during the last week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical evaluations results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait speed (m/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait time: 10-meter-Walk Test (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ambulation status: Functional Ambulation Category (points)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline levels of fecal short-chain fatty acid (acetate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: apnea-hypopnea index (OSA severity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: minimum and mean nocturnal oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time spent under SpO2<90% and under SpO2<80%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: T1ρ alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MK value alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-dimensional error measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal Bone Loss in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Coincidence rate of total number of oxygen reduction events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Allergan Fine Lines Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative alpha-band power in sensorimotor cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Relative beta-band power in sensorimotor cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: brain vulnerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Program completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention session completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximum Observed Concentration (Cmax) of PF-07817883
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration -Time Curve From Time Zero (0) Extrapolated to Infinite Time (AUCinf) of PF-07817883
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of MCCB
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gynecological Cancers Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of TEAEs/SAEs leading to STX-241 dose reductions, interruptions or discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed Overall Response Rate (cORR) based on RECIST version 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients receiving planned neoadjuvant treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Richmond Agitation Sedation Scale Score (RASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with a ≥75% reduction in EASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain tissue perfusion and oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Computer Vision Syndrome severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of Tixel for Treatment of Actinic Keratosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Maximum plasma level (Cmax) of PCLX-001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum plasma level (Tmax) of PCLX-001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Measurement Using EORTC QLQ-C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life Measurement Using EORTC QLQ-LC13
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Aesthetic Improved Thighs of Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Medication Misuse
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Suicidal Behaviour
Endpoint domain: Adverse events/effects
Primary endpoint: Visibility of surgical site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of bronchopulmonary dysplasia (BPD) or death
Endpoint domain: Mortality/survival
Primary endpoint: Change of Kansas City Cardiomyopathy Questionnaire (KCCQ) - Clinical summary score (CSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) total symptom score (TSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary score (OSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects with Dose-Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with Treatment-emergent Adverse Events (AEs), Serious Adverse Events (SAEs) and immune-related Adverse Events (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with Treatment-emergent Infusion related reactions (IRRs)
Endpoint domain: Adverse events/effects